Literature DB >> 28835475

Stroke and methamphetamine use in young adults: a review.

Julia M Lappin1,2, Shane Darke1, Michael Farrell1.   

Abstract

BACKGROUND: Methamphetamine use and stroke are significant public health problems. Strokes among people aged below 45 years are much less common than in older age groups but have significant mortality and morbidity. Methamphetamine is a putative cause of strokes among younger people.
METHODS: A review of methamphetamine-related strokes was conducted. Bibliographic databases were searched until February 2017 for articles related to methamphetamine and stroke. Both haemorrhagic and ischaemic strokes were considered.
RESULTS: Of 370 articles screened, 77 were selected for inclusion. There were 81 haemorrhagic and 17 ischaemic strokes reported in case reports and series. Both types were approximately twice as common in males. Route of administration associated with haemorrhagic stroke was typically oral or injecting, but for ischaemic stroke inhalation was most common. Haemorrhagic stroke was associated with vascular abnormalities in a third of cases. One quarter of individuals completely recovered, and a third died following haemorrhagic stroke. One-fifth completely recovered, and one-fifth died following ischaemic stroke.
CONCLUSIONS: There is a preponderance of haemorrhagic strokes associated with methamphetamine use in young people, and methamphetamine-related stroke is associated with poor clinical outcomes. Mechanisms of methamphetamine-associated stroke include hypertension, vasculitis, direct vascular toxicity and vasospasm. In a period of rising worldwide methamphetamine use, the incidence of methamphetamine-related stroke will increase, with a consequent increase in the burden of disease contributed by such events. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cerebrovascular disease; epidemiology; stroke

Mesh:

Substances:

Year:  2017        PMID: 28835475     DOI: 10.1136/jnnp-2017-316071

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis.

Authors:  Emily Stockings; Lucy Thi Tran; Thomas Santo; Amy Peacock; Sarah Larney; Damian Santomauro; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2019-07-28       Impact factor: 6.526

2.  Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.

Authors:  Dionne E Swor; Matthew B Maas; Sandeep S Walia; David P Bissig; Eric M Liotta; Andrew M Naidech; Kwan L Ng
Journal:  Neurology       Date:  2019-05-29       Impact factor: 9.910

Review 3.  Cerebrovascular and cardiovascular diseases caused by drugs of abuse.

Authors:  Yuichi Akasaki; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2019-12-05       Impact factor: 3.872

Review 4.  Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach.

Authors:  Jiri Polivka; Jiri Polivka; Martin Pesta; Vladimir Rohan; Libuse Celedova; Smit Mahajani; Ondrej Topolcan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2019-02-20       Impact factor: 6.543

5.  Bilateral carotid artery dissection associated with Eagle syndrome in a drug-addicted young adult with stroke: a case report.

Authors:  Yongjun Cao; Jijun Shi; Dai Shi; Chenchen Liu; Lijia Wang
Journal:  Neurol Sci       Date:  2022-05-23       Impact factor: 3.830

6.  Kratom Adulterated with Phenylethylamine and Associated Intracerebral Hemorrhage: Linking Toxicologists and Public Health Officials to Identify Dangerous Adulterants.

Authors:  Nicholas Nacca; Rachel F Schult; Lingyun Li; David C Spink; Gary Ginsberg; Kristen Navarette; Jeanna Marraffa
Journal:  J Med Toxicol       Date:  2019-11-11

7.  Association between recent cannabinoid use and acute ischemic stroke.

Authors:  Carmela V San Luis; Christa O'Hana S Nobleza; Shashank Shekhar; Rebecca Sugg; Darren J Villareal; Tapan Mehta; Shreyas Gangadhara
Journal:  Neurol Clin Pract       Date:  2020-08

Review 8.  Clinical perspectives on ischemic stroke.

Authors:  Atsushi Mizuma; Midori A Yenari
Journal:  Exp Neurol       Date:  2021-01-10       Impact factor: 5.330

Review 9.  Responding to global stimulant use: challenges and opportunities.

Authors:  Michael Farrell; Natasha K Martin; Emily Stockings; Annick Bórquez; Javier A Cepeda; Louisa Degenhardt; Robert Ali; Lucy Thi Tran; Jürgen Rehm; Marta Torrens; Steve Shoptaw; Rebecca McKetin
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

Review 10.  Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.

Authors:  Beth A Leeman-Markowski; Jesse Adams; Samantha P Martin; Orrin Devinsky; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2020-12-24       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.